Celestial Biolabs Ltd.
BSE: 532871 | Sector: Health care |
NSE: CELESTIAL | ISIN Code: INE221I01017 |
BSE 00:00 | 11 Mar | Celestial Biolabs Ltd |
NSE 05:30 | 01 Jan | Celestial Biolabs Ltd |
OPEN | 2.02 |
PREVIOUS CLOSE | 2.02 |
VOLUME | 124 |
52-Week high | 2.02 |
52-Week low | 0.00 |
P/E | |
Mkt Cap.(Rs cr) | 5 |
Buy Price | 2.01 |
Buy Qty | 450.00 |
Sell Price | 2.02 |
Sell Qty | 1876.00 |
Celestial Biolabs Ltd. (CELESTIAL) - Market Capital
Market Cap
COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
Sun Pharma.Inds. | 915.20 | -0.39 | 966.90 | 733.95 | 219583.93 |
Divi's Lab. | 3911.05 | 0.64 | 5425.00 | 3365.10 | 103818.82 |
Cipla | 1034.25 | -0.98 | 1083.15 | 850.00 | 83463.97 |
Dr Reddy's Labs | 4156.00 | 0.22 | 5078.80 | 3655.00 | 69172.47 |
Apollo Hospitals | 4373.20 | -0.53 | 5930.70 | 3365.90 | 62877.87 |
Torrent Pharma. | 1555.70 | -0.32 | 1652.23 | 1242.50 | 52651.11 |
Abbott India | 20395.55 | -0.12 | 23902.30 | 15525.00 | 43340.54 |
Piramal Enterp. | 1727.30 | -0.26 | 3013.00 | 1561.00 | 41222.01 |
Biocon | 313.00 | -0.27 | 410.50 | 305.00 | 37578.78 |
Gland Pharma | 2260.90 | -2.53 | 4350.00 | 2180.10 | 37237.02 |
Alkem Lab | 3111.65 | -1.30 | 4067.70 | 2835.00 | 37199.78 |
Zydus Lifesci. | 357.20 | -2.02 | 592.00 | 319.40 | 36566.56 |
Max Healthcare | 375.30 | -0.70 | 472.60 | 272.65 | 36390.21 |
Aurobindo Pharma | 568.55 | -0.44 | 929.20 | 503.40 | 33311.34 |
Lupin | 667.95 | 1.17 | 1158.90 | 583.05 | 30368.35 |
Laurus Labs | 545.25 | 0.27 | 723.55 | 433.20 | 29299.01 |
Ipca Labs. | 1015.15 | -0.99 | 1383.55 | 831.40 | 25754.36 |
Glaxosmi. Pharma | 1407.85 | 0.96 | 1917.00 | 1372.80 | 23850.39 |
Syngene Intl. | 564.55 | -1.02 | 686.00 | 508.10 | 22662.73 |
Dr Lal Pathlabs | 2424.10 | 1.00 | 4243.00 | 1805.10 | 20204.87 |
Quick Links for Celestial Biolabs:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices